Ryder Neil S
Infectious Diseases, Novartis Institutes for BioMedical Research, Inc., 500 Technology Square, Cambridge, MA 02139, USA.
Expert Opin Investig Drugs. 2007 Dec;16(12):1867-78. doi: 10.1517/13543784.16.12.1867.
Of the drugs dropped from development in 2006, 11 were being developed for infectious diseases. Of these, nine were for viral diseases, including four against HIV, two against hepatitis C virus and one each against respiratory syncytial virus, severe acute respiratory syndrome (coronavirus) and a variety of viruses. The nine antiviral agents comprised six synthetic small-molecule compounds, one peptide, one monoclonal antibody and a vaccine. The remaining two agents were a vaccine for Pseudomonas aeruginosa infection, and lipid-based agent for septic shock. Each of these drugs is briefly reviewed and reasons for failure are discussed.
在2006年停止研发的药物中,有11种是针对传染病进行研发的。其中,9种是针对病毒性疾病,包括4种抗HIV药物、2种抗丙型肝炎病毒药物以及各1种抗呼吸道合胞病毒、严重急性呼吸综合征(冠状病毒)和多种病毒的药物。这9种抗病毒药物包括6种合成小分子化合物、1种肽、1种单克隆抗体和1种疫苗。其余两种药物分别是用于铜绿假单胞菌感染的疫苗和用于感染性休克的脂质类药物。本文将对每种药物进行简要回顾,并探讨其失败的原因。